IL-4-loaded alginate/chitosan multilayer films for promoting angiogenesis through both direct and indirect means

[1]  Zhenjiang Ma,et al.  Evaluation of Interleukin-4-Loaded Sodium Alginate-Chitosan Microspheres for Their Support of Microvascularization in Engineered Tissues. , 2021, ACS biomaterials science & engineering.

[2]  J. Weng,et al.  Alginate/chitosan modified immunomodulatory titanium implants for promoting osteogenesis in vitro and in vivo. , 2021, Materials science & engineering. C, Materials for biological applications.

[3]  F. O'Brien,et al.  In vitro vascularization of tissue engineered constructs by non-viral delivery of pro-angiogenic genes. , 2021, Biomaterials science.

[4]  S. Levenberg,et al.  Macrophages of diverse phenotypes drive vascularization of engineered tissues , 2020, Science Advances.

[5]  J. Weng,et al.  Alginate/chitosan multilayer films coated on IL-4-loaded TiO2 nanotubes for modulation of macrophage phenotype. , 2019, International journal of biological macromolecules.

[6]  Jichun Liu,et al.  Nanotubular TiO2 regulates macrophage M2 polarization and increases macrophage secretion of VEGF to accelerate endothelialization via the ERK1/2 and PI3K/AKT pathways , 2019, International journal of nanomedicine.

[7]  T. Skaria,et al.  IL-4 Causes Hyperpermeability of Vascular Endothelial Cells through Wnt5A Signaling , 2016, PloS one.

[8]  M. Ferrari,et al.  IL-4 Release from a Biomimetic Scaffold for the Temporally Controlled Modulation of Macrophage Response , 2016, Annals of Biomedical Engineering.

[9]  G. Vunjak‐Novakovic,et al.  The role of macrophage phenotype in vascularization of tissue engineering scaffolds. , 2014, Biomaterials.

[10]  D. Mooney,et al.  Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors. , 2013, Biomaterials.

[11]  Liping Tang,et al.  Dual growth factor releasing multi-functional nanofibers for wound healing. , 2013, Acta biomaterialia.

[12]  A. Nagy,et al.  CCR2 recruits an inflammatory macrophage subpopulation critical for angiogenesis in tissue repair. , 2012, Blood.

[13]  Narutoshi Hibino,et al.  A critical role for macrophages in neovessel formation and the development of stenosis in tissue‐engineered vascular grafts , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[14]  T. Wynn,et al.  Protective and pathogenic functions of macrophage subsets , 2011, Nature Reviews Immunology.

[15]  Didier Y. R. Stainier,et al.  Molecular control of endothelial cell behaviour during blood vessel morphogenesis , 2011, Nature Reviews Molecular Cell Biology.

[16]  Won Hee Lee,et al.  Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium , 2010, Inflammation Research.

[17]  Y. Hayashi,et al.  The Local Injection of Peritoneal Macrophages Induces Neovascularization in Rat Ischemic Hind Limb Muscles , 2008, Cell transplantation.

[18]  J. Lavoie,et al.  IL-4 stimulates the expression of CXCL-8, E-selectin, VEGF, and inducible nitric oxide synthase mRNA by equine pulmonary artery endothelial cells. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[19]  Y. Ikada,et al.  Neovascularization and bone regeneration by implantation of autologous bone marrow mononuclear cells. , 2005, Biomaterials.

[20]  N. Klein,et al.  Interleukin‐4 increases the permeability of human endothelial cells in culture , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[21]  J. Ambati,et al.  Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[22]  R. Pakala,et al.  Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. , 2002, Cardiovascular radiation medicine.

[23]  Y. Iwamoto,et al.  The Activity of Soluble VCAM-1 in Angiogenesis Stimulated by IL-4 and IL-13 , 2000, The Journal of Immunology.

[24]  T. Shono,et al.  Novel biological functions of interleukin-4: formation of tube-like structures by vascular endothelial cells in vitro and angiogenesis in vivo. , 1998, Biochemical and biophysical research communications.

[25]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[26]  N Klein,et al.  Biological activity of IL-4 and IL-13 on human endothelial cells: functional evidence that both cytokines act through the same receptor. , 1996, International immunology.

[27]  B. Ryffel,et al.  Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. , 1996, Blood.

[28]  E. Shevach,et al.  IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. , 1996, Immunology today.

[29]  R. Callard,et al.  IL-4 regulates the morphology, cytoskeleton, and proliferation of human umbilical vein endothelial cells: relationship between vimentin and CD23. , 1993, International immunology.

[30]  W. Paul,et al.  Interleukin-4 : A Prototypic Immunoregulatory Lymphokine , 2003 .

[31]  Gordana Vunjak-Novakovic,et al.  Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds. , 2015, Biomaterials.

[32]  S. Verbruggen,et al.  Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo , 2013, Angiogenesis.

[33]  Won Hee Lee,et al.  Oxidative mechanisms of IL-4-induced IL-6 expression in vascular endothelium. , 2010, Cytokine.

[34]  K. Chen,et al.  Gene Expression Profile in Interleukin-4-Stimulated Human Vascular Endothelial Cells , 2004, Molecular medicine.

[35]  Yong Woo Lee,et al.  Redox-regulated mechanisms of IL-4-induced MCP-1 expression in human vascular endothelial cells. , 2003, American journal of physiology. Heart and circulatory physiology.

[36]  Y. W. Lee,et al.  IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. , 2001, Journal of molecular and cellular cardiology.

[37]  A. Manning,et al.  TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells , 1996 .

[38]  K. Schulze-Osthoff,et al.  Macrophage-derived angiogenesis factors. , 1991, Pharmacology & therapeutics.